This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 21, 2012

   NAMCP   AAMCN    AAIHDS    CME/CEU    JMCM    Contact Us  

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs

Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel


 Managed Healthcare News
Click Here to visit the Population Health Management Institute

Survey: Few ACOs ready for financial risk
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Few hospitals interested in becoming accountable care organizations are ready to take on financial risk, according to a survey from The Commonwealth Fund. There are already 154 ACOs serving nearly 2.4 million Medicare beneficiaries, and dozens more ACOs are involved in partnerships with private insurers. But so far, the majority of ACOs are pursuing models that allow them to share in any savings they achieve without losing money if they fail to cut costs. More

Aetna to buy Coventry, expand Medicare/Medicaid business
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health insurer Aetna Inc said it would buy rival Coventry Health Care Inc for $5.6 billion to increase its share of the fast-growing, U.S. government-backed Medicare and Medicaid programs. The purchase, which will add more than 5 million members to Aetna's ranks, comes just weeks after rival WellPoint struck a deal to buy Amerigroup Corp in a major expansion of its Medicaid business, administering the government's health plan for the poor. More

Now Hiring! Disability Examination Providers

The VA Locum Tenens Program seeks physicians and psychologists to perform disability examinations for general medicine and mental health conditions. Physicians will provide compensation and pension examinations for Veterans who file for disability claims. This position requires extensive travel around the country. Compensation package includes salary and full travel. Send your CV to or contact us at 1-866-664-1030.

WellPoint viewed worse by hospitals as UnitedHealth improves
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
WellPoint is the least popular carrier among hospital executives who have to negotiate with the company, an industry survey shows. The second-biggest U.S. health plan was ranked last among the six largest for-profit insurers, undercut by low ratings for rejecting claims and fixing wrongly-denied bills. WellPoint was viewed favorably by 27 percent of the executives polled. Cigna Corp. had the best reputation, at 71 percent, while UnitedHealth Group Inc., the only carrier bigger than WellPoint, improved for the second straight year at 44 percent. More

Indiana may stop low-income HIP enrollments in 2013
Evansville Courier & Press    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Indiana officials said that they might be forced to close enrollment in 2013 for the state's innovative health insurance program for low-income adults because federal authorities haven't approved funding for the plan beyond 2013. More

 FDA: New Treatments & Technology

St. Jude told to study defect in heart devices
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration ordered St. Jude Medical to conduct additional studies on patients implanted with heart-device components that were recalled last year and that have been linked to as many as 20 deaths. It also recommended that patients receive X-rays or other imaging to check for problems with their devices. More


Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE

Diabetes drug will soon be available as cheaper generic
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration gave the green light to the first generic version of the blockbuster diabetes drug Actos. It's often taken as a second-line treatment for type 2 diabetes among those who don't get a big enough blood sugar level drop with a first-line therapy such as metformin. More

Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE
Pharmaceutical products that make a difference
Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems and are always exploring new product opportunities. MORE

Click Here to visit the Oncology Institute

Cancer survivors, siblings miss more school days
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Years after they were first diagnosed, childhood cancer survivors — along with their brothers and sisters — missed twice as many school days as other children, according to a new study. Researchers found that childhood cancer survivors and their siblings missed — on average — 10 days of school during the 2009 academic year, while other students in the same school district missed an average of five days. More

Combination therapy hits skin cancer, boosting anti-tumor activity
UCLA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Treating metastatic melanoma by combining immunotherapy with a drug that inhibits the cancer-spreading activity of a common gene mutation significantly increased survival times in an animal model, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center. More

 Prevention & Wellness
Click Here to visit the Center for Preventive Health and Lifestyle Medicine

West Nile virus spreads faster
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
West Nile virus is spreading faster than it has in years, and the pace of the mosquito-borne disease is getting worse, health officials report. States are reporting more cases than usual, says Marc Fischer, a specialist in mosquito-borne diseases with the Centers for Disease Control and Prevention in Fort Collins, Colo. "There's been a lot of mosquito activity in most states" this year, Fischer says. More

Yo-yo dieting doesn't hurt metabolism
United Press International    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A history of yo-yo dieting does not negatively affect metabolism or the ability to lose weight in the long term, researchers say. Researchers said the affect of yo-yo dieting — the repetitive loss and regain of body weight, also called weight cycling — on the metabolism or a person's ability to lose weight in the long run has been unclear. More

Most American still eating too much salt
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most U.S. adults are eating far more sodium than dietary guidelines recommend, despite decades of health advice urging them to cut back, says a new study. The American Heart Association and the U.S. Department of Agriculture recommend that most healthy people limit the sodium they eat to 2,300 milligrams a day. More

 Genomics and Biotech
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute

Bad idea genes: Court partially rejects gene patent claims
Reuters via CNBC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A federal appeals court partially ruled against Myriad Genetics Inc. over the biotechnology company's effort to patent two genes linked to breast and ovarian cancer. A divided panel of the U.S. Federal Circuit Court of Appeals in Washington, D.C., upheld a 2010 ruling by a Manhattan federal judge that Myriad's claims directed to "comparing" or "analyzing" DNA sequences could not be patented. But it also ruled in favor of Myriad in backing the company's right to patent "isolated" DNA molecules, and its method for cancer screening via changes in "cell growth rates of novel, man-made transformed cells." More

The future of data: encoded in DNA
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the latest effort to contend with exploding quantities of digital data, researchers encoded an entire book into the genetic molecules of DNA, the basic building block of life, and then accurately read back the text. The experiment, reported in the journal Science, may point a way toward eventual data-storage devices with vastly more capacity for their size than today's computer chips and drives. More

 Behavioral Health
Click Here to visit the Behavioral Health Institute

More delays in brain growth seen with ADHD
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have uncovered more evidence that certain types of delays in brain development seem to be related to a heightened risk for attention-deficit hyperactivity disorder. A new study appearing in the current issue of the journal Biological Psychiatry found that development of the cortical surface — which covers the region of the brain known as the cerebral cortex — was slower in children with ADHD. More

Researchers develop prototype for male birth control pill
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have developed a prototype for an oral male contraceptive, raising expectations that a birth control pill for men may enter clinical trial testing within a year. Scientists tested a compound in mice and found it was able to penetrate the blood-testis barrier and disrupt spermatogenesis — the process in which sperm develop and become mature. The mice showed a reduction in the number and quality of sperm produced and were rendered infertile. More

"So far in 2012, 43 states have reported West Nile virus infections in people, birds or mosquitoes, according to the Centers for Disease Control and Prevention. A total 93 cases of West Nile virus in people, including 26 deaths, have been reported to the CDC."
Managed Care eNews
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Managed Care eNews was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Aug. 14, 2012
Aug. 7, 2012
July 31, 2012
July 24, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063